rxstat › Shortages › Mixed Salts Amphetamine
Mixed Salts Amphetamine (Adderall) shortage status
No current shortage
A stimulant medication used to treat attention deficit hyperactivity disorder (ADHD).
Shortage history
Reports by product
What's happening
There are no active shortage reports for Mixed Salts Amphetamine. Health Canada has 127 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Mixed Salts Amphetamine is classified under “PSYCHOSTIMULANTS AND NOOTROPICS” (ATC N06BA).
Recent changes
- Oct 30, 2026 Shortage resolved
- Oct 30, 2026 Shortage resolved
- Oct 27, 2026 Shortage resolved
- Oct 27, 2026 Shortage resolved
- Oct 27, 2026 Shortage resolved
- Oct 27, 2026 Shortage resolved
- Oct 27, 2026 Shortage resolved
- Oct 27, 2026 Status changed
- Oct 27, 2026 Status changed
- Oct 27, 2026 Status changed
- Oct 27, 2026 Status changed
- Oct 27, 2026 Status changed
- Oct 27, 2026 Status changed
- Oct 23, 2026 Estimated end date pushed back : Oct 23, 2026 → Oct 30, 2026
- Oct 16, 2026 New report filed
- Oct 9, 2026 Estimated end date pushed back : Oct 16, 2026 → Oct 30, 2026
- Oct 2, 2026 New report filed
- Aug 13, 2026 Estimated end date pushed back : Aug 14, 2026 → Aug 28, 2026
- Aug 13, 2026 Estimated end date pushed back : Aug 14, 2026 → Aug 21, 2026
- Jul 30, 2026 New report filed
Common questions
What is Mixed Salts Amphetamine used for?
A stimulant medication used to treat attention deficit hyperactivity disorder (ADHD).
When will Mixed Salts Amphetamine be back in stock in Canada?
Mixed Salts Amphetamine has no active shortage; supply is normal per Health Canada reports.
Why is Mixed Salts Amphetamine in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Related drugs (psychostimulants and nootropics)
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.